Skip to main content
Article
Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
Cancer Journal from Scientific American (1998)
  • Edith A. Perez, Mayo Clinic
  • Barry Lembersky, University of Pittsburgh
  • Paul Kaywin
  • Leonard Kalman
  • Karen Yocom, GlaxoSmithKline
  • Carl Friedman, GlaxoSmithKline
Publication Date
January 1, 1998
Citation Information
Edith A. Perez, Barry Lembersky, Paul Kaywin, Leonard Kalman, et al.. "Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy." Cancer Journal from Scientific American Vol. 4 Iss. 1 (1998) p. 52 - 58
Available at: http://works.bepress.com/leonard-kalman/13/